HOMOLOGY MEDICINES INC(NASDAQ:FIXX) stock News

FIXX Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: Homology Medicines, Inc.

Homology Medicines Declares Distribution to Common Stockholders

a year ago - By: BusinessInsider

FIXX Stock Earnings: Homology Medicines Beats EPS for Q4 2023

a year ago - By: InvestorPlace

FIXX Stock Earnings: Homology Medicines Beats EPS for Q4 2023

2 years ago - By: Kahn Swick & Foti, LLC

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

2 years ago - By: Benzinga

What's Going On With Homology Medicines Stock Today?

2 years ago - By: Benzinga

The Latest Analyst Ratings for Homology Medicines

2 years ago - By: Seeking Alpha

Homology Medicines gets non-compliance notice from Nasdaq (NASDAQ:FIXX)

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

2 years ago - By: Kahn Swick & Foti, LLC

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

2 years ago - By: Halper Sadeh LLC

FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders

2 years ago - By: Seeking Alpha

Homology Medicines stock slumps after merger deal

2 years ago - By: Q32 Bio

Q32 Bio and Homology Medicines Announce Merger Agreement

2 years ago - By: Homology Medicines, Inc.

Q32 Bio and Homology Medicines Announce Merger Agreement

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Reports Third Quarter 2023 Financial Results

2 years ago - By: Seeking Alpha

Homology Medicines stock spikes on strategic review

2 years ago - By: InvestorPlace - Mentions: INVO SIGA UFAB GBNH ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKU

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual Meeting

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual Meeting

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics Meeting

2 years ago - By: Homology Medicines, Inc.

Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

2 years ago - By: Seeking Alpha

Homology Medicines gets new chief medical officers (NASDAQ:FIXX)

2 years ago - By: Homology Medicines, Inc.

HOMOLOGY MEDICINES INC (FIXX) Stock News

FIXX Latest News, Press Relases and Analysis

Homology Medicines Declares Distribution to Common Stockholders

FIXX Stock Earnings: Homology Medicines Beats EPS for Q4 2023

FIXX Stock Earnings: Homology Medicines Beats EPS for Q4 2023

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

What's Going On With Homology Medicines Stock Today?

The Latest Analyst Ratings for Homology Medicines

Homology Medicines gets non-compliance notice from Nasdaq (NASDAQ:FIXX)

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders

Homology Medicines stock slumps after merger deal

Q32 Bio and Homology Medicines Announce Merger Agreement

Q32 Bio and Homology Medicines Announce Merger Agreement

Homology Medicines Reports Third Quarter 2023 Financial Results

Homology Medicines stock spikes on strategic review

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKU

Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual Meeting

Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights

Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual Meeting

Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics Meeting

Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

Homology Medicines gets new chief medical officers (NASDAQ:FIXX)

Homology Medicines Announces Promotion of Julie Jordan, M.D., to Chief Medical Officer